0001144204-15-042914.txt : 20150717 0001144204-15-042914.hdr.sgml : 20150717 20150716192605 ACCESSION NUMBER: 0001144204-15-042914 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20150717 DATE AS OF CHANGE: 20150716 EFFECTIVENESS DATE: 20150717 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRANSGENOMIC INC CENTRAL INDEX KEY: 0001043961 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 911789357 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-243939 FILM NUMBER: 15992433 BUSINESS ADDRESS: STREET 1: 12325 EMMET ST CITY: OMAHA STATE: NE ZIP: 68164 BUSINESS PHONE: 4027385480 MAIL ADDRESS: STREET 1: 12325 EMMET STREET CITY: OMAHA STATE: NE ZIP: 68164 D 1 primary_doc.xml X0707 D LIVE 0001043961 TRANSGENOMIC INC 12325 EMMET STREET OMAHA NE NEBRASKA 68164 (402) 452-5400 DELAWARE None None Corporation true Paul Kinnon c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Executive Officer Director President, Chief Executive Officer, Interim Chief Financial Officer and Secretary, Director Leon F. Richards c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Executive Officer Robert M. Patzig c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Doit L. Koppler, II c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director John D. Thompson c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Michael A. Luther c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Mya Thomae c/o Transgenomic, Inc. 12325 Emmet Street Omaha NE NEBRASKA 68164 Director Biotechnology Decline to Disclose 06b false 2015-07-07 false true true false 0 Craig-Hallum Capital Group LLC 121395 None None 222 SOUTH NINTH STREET, SUITE 350 MINNEAPOLIS MN MINNESOTA 55402 CA CALIFORNIA MN MINNESOTA false 3039760 3039760 0 false 2 212783 0 In addition to the above, for $50, the Company issued to Craig-Hallum Capital Group LLC a 5 year warrant to purchase up to 107,033 shares of common stock with an exercise price of $1.66 per share, which will be exercisable beginning on January 7, 2016. 0 false TRANSGENOMIC INC /s/ Leon Richards Leon Richards Chief Accounting Officer 2015-07-16